Expression of the human immunodeficiency virus gag gene products by a replication-incompetent herpes simplex virus vector (Q45754922)

15 December 2017

title

Expression of the human immunodeficiency virus gag gene products by a replication-incompetent herpes simplex virus vector (English)

1 reference

15 December 2017

0 references

Kessler J

1

1 reference

15 December 2017

Muller J

series ordinal

2

1 reference

15 December 2017

Weir JP

series ordinal

3

1 reference

15 December 2017

publication date

1 March 1998

1 reference

15 December 2017

published in

Virus Research

1 reference

15 December 2017

volume

54

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

31-38

1 reference

15 December 2017

Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Development and application of herpes simplex virus vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Characterization of long terminal repeat sequences of HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

Plasmid insertion vectors that facilitate construction of herpes simplex virus gene delivery vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

The use of beta-galactosidase as a marker gene to define the regulatory sequences of the herpes simplex virus type 1 glycoprotein C gene in recombinant herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2898%2900004-5

7 January 2021

10.1016/S0168-1702(98)00004-5

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

9660069

1 reference

15 December 2017